Analysts Downgrade Clearwater Analytics to Market Perform
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 22 2025
0mins
Source: Benzinga
- Rating Downgrade: William Blair analyst Dylan Becker downgraded Clearwater Analytics Holdings, Inc. (NYSE:CWAN) from Outperform to Market Perform, indicating a cautious outlook on the stock's future performance.
- Stock Performance: Clearwater Analytics shares closed at $22.25 on Friday, reflecting market concerns about its prospects, which may impact investor confidence and lead to decreased liquidity in the short term.
- Price Target Reduction: Citigroup analyst Samantha Semenkow lowered the price target for Amicus Therapeutics, Inc. (NASDAQ:FOLD) from $17 to $14.5, suggesting a weakened expectation for its future profitability, which could affect its stock price trajectory.
- Market Reaction: Amicus Therapeutics shares closed at $14.18 on Friday, indicating market caution regarding its outlook, potentially prompting investors to reassess their investment strategies.
Analyst Views on CWAN
Wall Street analysts forecast CWAN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CWAN is 27.83 USD with a low forecast of 24.55 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 24.290
Low
24.55
Averages
27.83
High
36.00
Current: 24.290
Low
24.55
Averages
27.83
High
36.00
About CWAN
Clearwater Analytics Holdings, Inc. is a provider of comprehensive cloud-native platforms for institutional investors across global public and private markets. The Company’s single-instance, multi-tenant architecture delivers real-time data and artificial intelligence (AI)-driven insights throughout the investment lifecycle. The platform eliminates information silos by integrating portfolio management, trading, investment accounting, reconciliation, regulatory reporting, performance, compliance, and risk analytics in one unified system. The Company serves insurers, asset managers, hedge funds, banks, corporations, and governments. The Company is also a provider of enterprise risk analytics and developer infrastructure. Its capabilities in complex portfolio management across both public and private markets include structured products, private credit, and derivatives.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
